Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Core binding factor acute myeloid leukemia (AML) comprises two subtypes with distinct cytogenetic abnormalities of either t(8;21)(q22;q22) or inv(16)(p13q22)/t(16;16)(p13;q22). Since long-term response to chemotherapy in these leukemias is relatively good, allogeneic hematopoietic stem cell transpla...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Kazimierz Halaburda, Myriam Labopin, Audrey Mailhol, Gerard Socié, Charles Craddock, Mahmoud Aljurf, Dietrich Beelen, Jan J. Cornelissen, Jean-Henri Bourhis, Hélène Labussière-Wallet, Didier Blaise, Tobias Gedde-Dahl, Maria Gilleece, Ibrahim Yakoub-Agha, Ghulam Mufti, Jordi Esteve, Mohamad Mohty, Arnon Nagler
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Ferrata Storti Foundation 2020-06-01
Seri Bilgileri:	Haematologica
Online Erişim:	https://haematologica.org/article/view/9449
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!